Abstract
Nucleic acid vaccines have shown promise for infectious disease but not for cancer. Ying et al.1 have increased the immunogenicity of naked nucleic acid encoding β-galactosidase (β-gal) – a popular model tumour antigen – by constructing RNAs that use a Semliki forest virus-derived replicase to self replicate.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
